论文部分内容阅读
作者将 ＳｍｉｔｈＫｌｉｎｅ Ｂｅｅｃｈａｍ Ｂｉｏｌｏｇｉｃａｌｓ公司生产的新型麻疹、腮腺炎、风疹（ＭＭＲ）联合疫苗（ＳＢ ＭＭＲ）与目前市场上广泛使用的Ｍｅｒｃｋ ＭＭＲ进行了比较。采用单盲随机方法将４７０２名９～２４月龄健康儿童分成８组，３５０７人接种
The authors compared the new measles, mumps and rubella (MMR) combination vaccine (SB MMR) produced by SmithKline Beecham Biologicals to the Merck MMR currently in widespread use in the market. 4702 9 ~ 24-month-old healthy children were divided into 8 groups and 3507 were vaccinated by single-blind randomized method